Michael Freeman
Faculty Member
Last active: 2/8/2017

  1. Thoughts on the future of research, teaching, and testing in the biological sciences of radiation oncology. Hallahan DE, Freeman ML (2014) Int J Radiat Oncol Biol Phys 88(1): 1-2
    › Primary publication · 24331646 (PubMed)
  2. The NADH oxidase ENOX1, a critical mediator of endothelial cell radiosensitization, is crucial for vascular development. Venkateswaran A, Sekhar KR, Levic DS, Melville DB, Clark TA, Rybski WM, Walsh AJ, Skala MC, Crooks PA, Knapik EW, Freeman ML (2014) Cancer Res 74(1): 38-43
    › Primary publication · 24247717 (PubMed) · PMC3947320 (PubMed Central)
  3. Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization. Sekhar KR, Benamar M, Venkateswaran A, Sasi S, Penthala NR, Crooks PA, Hann SR, Geng L, Balusu R, Abbas T, Freeman ML (2014) Int J Radiat Oncol Biol Phys 89(5): 1106-1114
    › Primary publication · 25035215 (PubMed) · PMC4105849 (PubMed Central)
  4. Oncology scan--The concept of personalized medicine and the radiation response of tumors. Freeman ML (2014) Int J Radiat Oncol Biol Phys 88(3): 546-8
    › Primary publication · 24524335 (PubMed)
  5. Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells. Schultz MA, Hagan SS, Datta A, Zhang Y, Freeman ML, Sikka SC, Abdel-Mageed AB, Mondal D (2014) PLoS One 9(1): e87204
    › Primary publication · 24466341 (PubMed) · PMC3899380 (PubMed Central)
  6. The novel antiangiogenic VJ115 inhibits the NADH oxidase ENOX1 and cytoskeleton-remodeling proteins. Venkateswaran A, Friedman DB, Walsh AJ, Skala MC, Sasi S, Rachakonda G, Crooks PA, Freeman ML, Sekhar KR (2013) Invest New Drugs 31(3): 535-44
    › Primary publication · 23054211 (PubMed) · PMC3553230 (PubMed Central)
  7. Nrf2 is essential for the expression of lipocalin-prostaglandin D synthase induced by prostaglandin D2. Kim KH, Sadikot RT, Xiao L, Christman JW, Freeman ML, Chan JY, Oh YK, Blackwell TS, Joo M (2013) Free Radic Biol Med : 1134-1142
    › Primary publication · 24029383 (PubMed) · PMC3972891 (PubMed Central)
  8. NADPH oxidase and Nrf2 regulate gastric aspiration-induced inflammation and acute lung injury. Davidson BA, Vethanayagam RR, Grimm MJ, Mullan BA, Raghavendran K, Blackwell TS, Freeman ML, Ayyasamy V, Singh KK, Sporn MB, Itagaki K, Hauser CJ, Knight PR, Segal BH (2013) J Immunol 190(4): 1714-24
    › Primary publication · 23296708 (PubMed) · PMC3563868 (PubMed Central)
  9. Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line. Goode GD, Ballard BR, Manning HC, Freeman ML, Kang Y, Eltom SE (2013) Int J Cancer 133(12): 2769-80
    › Primary publication · 23733406 (PubMed) · PMC3797219 (PubMed Central)
  10. Doxorubicin-mediated bone loss in breast cancer bone metastases is driven by an interplay between oxidative stress and induction of TGFβ. Rana T, Chakrabarti A, Freeman M, Biswas S (2013) PLoS One 8(10): e78043
    › Primary publication · 24205081 (PubMed) · PMC3813496 (PubMed Central)